• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Mol Cell. Author manuscript; available in PMC Mar 13, 2010.
Published in final edited form as:
PMCID: PMC2749619

Structural Basis for Recognition of Diubiquitins by NEMO


NEMO is the regulatory subunit of the IκB kinase (IKK) in NF-κB activation and its CC2-LZ region interacts with Lys63 (K63)-linked polyubiquitin to recruit IKK to receptor signaling complexes. In vitro, CC2-LZ also interacts with tandem diubiquitin. Here we report the crystal structure of CC2-LZ with two dimeric coiled coils representing CC2 and LZ, respectively. Surprisingly, mutagenesis and nuclear magnetic resonance experiments reveal that the binding sites for diubiquitins at LZ are composites of both chains and that each ubiquitin in diubiquitins interacts with symmetrical NEMO asymmetrically. For tandem diubiquitin, the first ubiquitin uses the conserved hydrophobic patch and the C-terminal tail while the second ubiquitin uses an adjacent surface patch. For K63-linked diubiquitin, the proximal ubiquitin uses its conserved hydrophobic patch while the distal ubiquitin mostly employs the C-terminal arm including the K63-linkage residue. These studies uncover the energetics and the common U-shaped geometry for mutual recognition of NEMO and diubiquitins.


NF-κB proteins are evolutionarily conserved master regulators of immune and inflammatory responses (Gilmore, 2006). They play critical roles in a wide array of biological processes including innate and adaptive immunity, oncogenesis and development. They are activated in response to ligation of many receptors including T-cell receptors, B-cell receptors, members of the tumor necrosis factor (TNF) receptor superfamily and the Toll-like receptor/interleukin-1 receptor (TLR/IL-1R) superfamily. The Ser/Thr-specific IκB kinase (IKK) signalosome is at the bottleneck for NF-κB activation because activated IKK phosphorylates IκB, leading to Lys48 (K48)-linked polyubiquitination and subsequent degradation of IκB by the proteasome (Scheidereit, 2006). The freed NF-κB dimers translocate to the nucleus to mediate specific target gene transcription.

The IKK signalosome contains the kinase, IKKα and/or IKKβ, and the highly conserved regulatory protein NEMO (also known as IKKγ or FIP-3) (Scheidereit, 2006). IKK activity relies on the interaction between the kinase and NEMO. In cells lacking NEMO, IKKα and IKKβ cannot be activated by any of the classical NF-κB inducers. Sequence analysis of NEMO indicates a high helical content with an N-terminal kinase-binding domain (KBD), three coiled coil regions (CC1, CC2 and LZ) and a zinc finger (ZF) domain (Scheidereit, 2006).

IKK activation by multiple receptor signaling pathways has been shown to depend on Lys63 (K63)-linked non-degradative polyubiquitination (Chen, 2005). For the IL-1 and the Toll-like receptor signaling pathways, the RING domain ubiquitin (Ub) ligase (E3) TRAF6, in conjunction with the specific dimeric Ub conjugating enzyme Ubc13/Uev1A complex (E2), is responsible for K63-linked polyubiquitination of itself and downstream proteins such as IRAK1. For the TNFα signaling pathway, the RIP1 kinase is K63-polyubiquitinated (Ea et al., 2006; Wu et al., 2006). Similarly, K63-linked polyubiquitination of T-cell signaling mediators MALT1 (Oeckinghaus et al., 2007) and Bcl10 (Wu and Ashwell, 2008) is critical for NF-κB activation.

Recent studies have shown that direct binding of NEMO to K63-linked polyubiquitin (poly-Ub) chains is crucial for IKK recruitment and NF-κB activation (Ea et al., 2006; Wu et al., 2006). A yeast two-hybrid screen pulled out tandem diubiquitin (di-Ub) or triubiquitin (tri-Ub) molecules, which are endogenous Ub precursors, as NEMO interacting proteins (Wu et al., 2006). NEMO interacted with K63-polyubiquitinated RIP1 in the TNFα signaling pathway (Ea et al., 2006) and bound K63-linked poly-Ub in vitro (Ea et al., 2006; Wu et al., 2006). Presumably, the K63-linked poly-Ub chains serve as an extended scaffold for signal-dependent NEMO recruitment and oligomerization.

Deletion mapping experiments revealed that the region encompassing the CC2 and LZ domains was necessary and sufficient for Ub interaction (Ea et al., 2006; Wu et al., 2006). The interaction required a minimum of di-Ub and little interaction could be detected with monoubiquitin (mono-Ub). A region of high homology with NEMO within the CC2-LZ region has been identified in the NEMO-like proteins Optineurin and ABIN1-3 and was named the UBAN domain (Wagner et al., 2008). Interestingly, naturally occurring point mutations of NEMO in this region have been shown to impair NF-κB activation and cause a diverse array of serious X-linked diseases such as ectodermal dysplasia and immunodeficiency in human patients (Courtois and Gilmore, 2006; Filipe-Santos et al., 2006; Sebban-Benin et al., 2007). The immunological, skin and hair features observed in these patients may result from defective responses to many extracellular and cell surface ligands such as EDA, LPS, IL-1, IL-18, TNFα, TLR2 and CD40L.

The molecular mechanism of di-Ub recognition by NEMO is entirely unknown. Here, we report the crystal structure of the CC2-LZ region of NEMO, which revealed an elongated dimeric molecule with two coiled coils and an intervening bend. Because of the ability of the CC2-LZ region to interact with both tandem and K63-linked di-Ub, we used the former as a reasonable starting point to address NEMO: K63-linked di-Ub interaction. The N-terminus and the K63 side chain of Ub are spatially proximal so that tandem and K63-linked di-Ub may have similar structural properties in NEMO interaction. To map the mutual binding sites of NEMO with tandem and K63-linked di-Ub, we used a combination of structure-based mutagenesis and nuclear magnetic resonance (NMR). Surprisingly, the binding site of NEMO for tandem and K63-linked di-Ub, which is localized to the LZ coiled coil, is a composite of both chains of the NEMO dimer, unlike known helical motifs involved in Ub interactions (Hurley et al., 2006). This Ub-binding site of NEMO explains many NEMO disease-causing mutations. Our mutagenesis data on individual Ub molecules within tandem di-Ub and K63-linked di-Ub and NMR chemical shift perturbation data using selectively labeled di-Ub showed both similarities and differences in the modes of these NEMO: di-Ub interactions. The mapped mutual interaction surfaces allowed information-restrained docking to generate both NEMO: tandem di-Ub and NEMO: K63-linked di-Ub models. For tandem di-Ub, the conserved hydrophobic patch of the first Ub and an adjacent and overlapping surface patch of the second Ub clasp around NEMO. For K63-linked di-Ub, the conserved hydrophobic patch of the proximal Ub contributes more to the overall NEMO interaction than that of the distal Ub and the C-terminal tails of both proximal and distal Ub including G76 of the distal Ub are involved in NEMO interaction. Collectively, these studies provided unforeseen insight into the mutual recognition of NEMO and di-Ub.


The CC2-LZ Region is Dimeric and Each CC2-LZ Dimer Interacts with One Tandem or K63-linked di-Ub

As a first step towards understanding the interaction of NEMO with poly-Ub, we expressed and purified the putative Ub-binding domain comprising the CC2-LZ region of human NEMO (residues 251-350). Gel filtration analysis showed a homogeneous size distribution of CC2-LZ. The oligomerization state could not be determined because the coiled coil structure of the region is likely to be non-globular. To accurately determine the native molecular mass of CC2-LZ, we used multi-angle light scattering (MALS) in conjunction with refractive index, which measures molecular mass independent of its molecular shape. The measurement revealed a homogeneous species for CC2-LZ with a molecular mass of 27.0 kD (0.1% error). Because the calculated molecular weight of the CC2-LZ construct is 12.719 kD, this measurement is consistent with a dimeric structure of CC2-LZ (Figure 1A). Similarly, MALS measurement of the entire C-terminal region of NEMO comprising CC2, LZ and ZF domains (residues 246-419) also revealed a homogeneous dimer (Figure 1B). This is in contrast to the previously suggested trimeric architecture of the CC2-LZ region of mouse NEMO for which the equilibrium ultracentrifugation experiment performed in the presence of the detergent n-dodecyl-β-d-maltopyranoside (DDM) showed equilibrium between monomer, dimer and trimer (Agou et al., 2002).

Figure 1
CC2-LZ of NEMO is dimeric and interacts with di-Ub at 2:1 stoichiometry

Consistent with previous data (Ea et al., 2006; Wu et al., 2006), the CC2-LZ construct interacted with tandem di-Ub or K63-linked di-Ub as shown by pull-down experiments using His-tagged NEMO (see below). Using gel filtration coupled with MALS, we showed that each CC2-LZ dimer forms a stoichiometric complex with one tandem di-Ub (Figure 1C). The measured molecular mass of the complex is 44.7 kD while the calculated molecular weight for two CC2-LZ and one di-Ub is 42.6 kD. We further measured the binding affinity of CC2-LZ with mono-Ub, tandem di-Ub and K63-linked di-Ub quantitatively using isothermal titration calorimetry (ITC). No interaction could be detected between NEMO and mono-Ub while dissociation constants of 1.4 μM and 131 μM were obtained for the NEMO: tandem di-Ub and the NEMO: K63-linked di-Ub interactions, respectively (Figure 1D, 1E). The measured stoichiometries for the titration of NEMO into tandem and K63-linked di-Ub were 2.1±0.02 and 2.0±0.14, respectively, demonstrating that each di-Ub interacts with one NEMO dimer. The fairly low affinity of NEMO to K63-linked di-Ub suggests that longer chain of K63-linked poly-Ub may be required for its interaction with NEMO in cells (Wu et al., 2006), likely through higher order oligomerization of NEMO.

Crystal Structure of CC2-LZ

We crystallized a shorter version of the CC2-LZ region of NEMO (residues 246-337). This region exists in monomer-dimer equilibrium in solution as shown by MALS (Figure 2A), but forms a dimeric coiled coil in the crystal (Figure 2B). The structure was initially determined at 4.0 Å resolution using single-wavelength anomalous diffraction on a selenomethionyl crystal (Se-SAD) (Table 1). The solvent content of the crystal is approximately 73%. Although the electron density map revealed the overall shape of the structure, it was not of sufficient quality for sequence fitting. To enhance anomalous signal and improve phasing, we generated mutations to Met on several conserved hydrophobic residues at the predicted a or d positions of the CC2-LZ and were able to obtain a 3.2 Å resolution Se-SAD data set on the L263M/L267M double mutant (Table 1). Similar to the wild type (WT) protein, the mutant efficiently pulled down tandem and K63-linked di-Ub (data not shown). The resulting electron density map was of sufficient quality to allow model building and refinement.

Figure 2
Structure of CC2-LZ
Table 1
Crystallographic statistics

The structure contains ordered residues 263-333 for one chain and residues 267-329 for the other chain. The structure revealed an elongated dimer of CC2-LZ that spans approximately 110 Å (Figure 2B). Based on the secondary structure definition in Procheck, each chain of the CC2-LZ dimer forms a continuous helix. However, there is a prominent kink of about 20° near residue P299, which may be used as the boundary between the CC2 coiled coil and the LZ coiled coil. This boundary is somewhat different from the previous definition of the CC2 and LZ region based on sequence analyses (Scheidereit, 2006). The full CC2-LZ structure does not have 2-fold symmetry. When the two chains of CC2 are structurally aligned, the LZ chains are not superimposed and vice versa. However, the individual CC2 and LZ coiled coils almost obey 2-fold symmetry with CC2 having 179° rotation and LZ having 171° rotation between the two chains. The a and d positions of both CC2 and LZ are often non-canonical dimeric coiled coil residues including charged residues (Figure 2C), perhaps explaining the apparent weak dimerization of the CC2-LZ construct (residues 246-337). At the dimerization interface, the hydrophobic portions of these residues pack against each other with their hydrophilic portions facing outwards (Figure 2D). It has been shown that NEMO forms intermolecular disulfide bonds through C54 and C347 (Herscovitch et al., 2008). C347 is within the longer CC2-LZ construct (residues 251-350), which may stabilize dimerization via the intermolecular disulfide bond.

Mapping of residues in the CC2-LZ region that are conserved among NEMO, Optineurin, and ABIN1-3 onto the structure revealed two symmetrical surface patches at the LZ region (Figure 2C, 2E). In contrast, the CC2 region does not contain any strictly conserved residues. Interestingly, the conserved surface patches are formed compositely from both chains of the dimeric coiled coil. They each include residues L301, Q304, D311, and E315 from one chain and F312, R316, R319, E320 and L329 from the other chain. The surface conservation pattern clearly suggests that the LZ region harbors the Ub binding site of NEMO. The LZ region coincides with the UBAN domain common to NEMO, Optineurin and ABIN1-3 (Wagner et al., 2008).

Identification of a Composite Ub-binding Site that is Completely Different from the UIM/MIU Motif

Because repeated attempts to crystallize CC2-LZ in complex with di-Ub failed to yield any useful crystals, we first used the mutagenesis approach to map the tandem di-Ub binding site in NEMO (Figure 2C, ,3A).3A). Mutational effects were assessed by pull-down experiments using His-tagged WT and mutant CC2-LZ of NEMO (residues 251-350) and non-tagged tandem di-Ub. The mutagenesis went through several stages. First, we mutated all conserved residues in the LZ/UBAN domain. Second, we mutated all Ala residues and additional hydrophobic residues in LZ, because we wondered whether NEMO interacts with Ub via a “cryptic” helical UIM or MIU motif, for which the consensus sequence includes an absolutely conserved Ala residue and several hydrophobic residues (Hurley et al., 2006). Third, we mutated all known NEMO disease mutations in the LZ region. Fourth, we produced conserved substitutions on the highly defective mutations. We found that even conserved mutations D311N, E315Q and F312Y are severely or partially defective in di-Ub binding, suggesting that the charges and the exact fit of the side chains are crucial for di-Ub interaction. Eventually, we generated structure-based mutations on almost all residues in the conserved LZ region. Collectively among the 38 mutations, V300D, I307N, Y308A, D311N, F312A, E315A/Q, Q317A/W and A323P/D nearly abolished the ability of NEMO to interact with tandem di-Ub (Figure 2C, ,3A).3A). L301A, Q304A, F312Y, Q313A and R319Q significantly decreased tandem di-Ub binding (Figure 2C, ,3A3A).

Figure 3
Structure-based mutagenesis of NEMO

To determine whether NEMO residues important for tandem di-Ub interaction are also critical for K63-linked di-Ub interaction, we enzymatically synthesized K63-linked di-Ub for use in pull-down by His-tagged NEMO (Piotrowski et al., 1997). We generated two Ub mutant constructs: K63R-Ub, and D77-Ub in which a D77 residue is appended to the last residue G76 of Ub. In a ubiquitination assay with E1 and the E2 complex Ubc13/Uev1A, these two Ub mutants together generate only K63-linked di-Ub with K63R-Ub as the distal Ub and D77-Ub as the proximal Ub (Piotrowski et al., 1997). When tested for binding to K63-linked di-Ub, all but one of the NEMO mutations had effects similar to tandem di-Ub (Figure 3B, Supplemental Figure S1). R319Q is significantly defective in binding to tandem di-Ub but appears to be WT in binding to K63-linked di-Ub. In general, these data confirm that tandem di-Ub is a good mimic for K63-linked di-Ub, but there may be subtle differences in their binding to NEMO.

To determine whether these mutations defective in tandem and K63-linked di-Ub binding also caused global disruption of the dimeric coiled coil structure, we utilized the ability of the WT CC2-LZ construct to form intermolecular disulfide bond at C347. In the absence of the reducing agent dithiothreitol (DTT), WT CC2-LZ migrated at the dimeric molecular weight on an SDS-PAGE (Figure 3C). Upon treatment with DTT, WT CC2-LZ migrated at the monomeric molecular weight (Figure 3A). We reasoned that if the mutations drastically destabilized the dimeric coiled coil, the disulfide bond would fail to form. All mutants that are defective in di-Ub binding showed the presence of the disulfide bonds, suggesting that the dimeric coiled coils were formed in these mutants (Figure 3C). Further confirmation of the dimeric nature of these mutants came from measurements by MALS (Figure 3D, Supplemental Figure S2). Therefore, these mutants do not appear to have destroyed the global conformation of the dimeric coiled coil.

Mapping of residues important for tandem and K63-linked di-Ub interaction onto the CC2-LZ structure showed that they form symmetrical composite Ub-binding sites (Figure 4). Each surface patch is formed from both chains, V300, L301, Q304, I307, Y308, D311 and E315 from one chain, F312, Q313, Q317 and A323 from the other chain (Figure 4A). A mixture of hydrophobic and hydrophilic components is present at the mapped Ub-binding site (Figure 4B, 4C). These residues are highly conserved, but not always identical in Optineurin and ABIN1-3, suggesting a similar, but not identical mode of Ub-binding in these NEMO-related proteins (Figure 2C). The two symmetrical surface patches of NEMO are clearly separated by residues at the sides that do not participate in Ub-binding (Figure 4B). The composite nature of the mapped Ub-binding site distinguishes itself from many helical motifs in Ub recognition such as the UIM and MIU in which a single helix contributes all the interactions (Hurley et al., 2006).

Figure 4
Mapped Ub-binding site of NEMO

The Mapped di-Ub Binding Site of NEMO is Important for NF-κB Activation

To determine whether the Ub-binding site of NEMO identified using in vitro biochemical assay is important for its cellular function, we picked a crucial residue E315 for functional assessment. E315A and E315Q mutations are severely defective in interactions with tandem and K63-linked di-Ub. E315A is also a naturally occurring disease-causing mutation (Filipe-Santos et al., 2006). 293 cells stably expressing the IL-1 receptor were stimulated or not with IL-1 and lysed. GST or the indicated NEMO GST-fusion proteins were used to pull down IRAK-1 in the cell lysates (Figure 3E). Whereas none of the constructs pulled down IRAK-1 in unstimulated cells, WT NEMO brought down ubiquitinated (but not unmodified) IRAK-1 from IL-1 stimulated cells. In contrast, the E315A mutant did not bring down IRAK-1 under these conditions.

To further explore the effect of the E315A mutation on physiologic signals leading to NF-κB activation, we stably expressed WT NEMO or its E315A mutant in NEMO-deficient murine embryonic fibroblasts (MEFs), and clones that expressed similar amounts of NEMO were selected for study. Degradation of IκB was used as a sensitive and specific indicator of IKK activity. Stimulation of the NEMO-deficient MEFs with either IL-1 (Figure 3F, top panel) or TNFα (Figure 3F, lower panel) did not cause IκB degradation. In contrast, IκB degradation was observed in MEFs reconstituted with WT NEMO upon stimulation with either IL-1 or TNFα in a dose-responsive fashion. Cells reconstituted with the E315A mutant also degraded IκB, but were much less sensitive to these cytokines. For example, 5- to 10-fold more IL-1 and 5-fold more TNFα were required to achieve the same degree of IκB degradation in cells expressing mutant NEMO as in those expressing WT NEMO. These data are representative of two (WT NEMO) and three (E315A NEMO) independent clones. Therefore, the E315A mutation impaired NEMO binding to ubiquitinated signaling intermediates and reduced the efficiency of receptor-mediated signaling for IKK activity. Defective di-Ub interactions in vitro for mutations of Y308 and F312 are consistent with previous results showing the failure of these mutant forms of NEMO to be activated by TRAF6 and mediate TNFα-induced NF-κB activation (Ea et al., 2006). Collectively, these data link in vitro poly-Ub binding to signal-dependent NF-κB activation in cells.

The Structure Explains NEMO Disease-causing Mutations

NEMO is located on the X chromosome and many of its mutations have been associated with distinct X-linked genetic diseases. At least five point mutations in the CC2-LZ region have been shown to cause NEMO dysfunction. The A288G, D311N, and A323P (Courtois and Gilmore, 2006; Sebban-Benin et al., 2007) mutations cause severe anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID), in which the patients suffer skin inflammation and impaired NF-κB activation in response to numerous stimuli such as TNFα, IL-1, and LPS. The E315A and R319Q mutations were identified as immunodeficiency against mycobacterial infections and caused impairment in IL-12 production (Filipe-Santos et al., 2006).

Our structure provides a mechanistic basis for some of these NEMO mutations. D311N and E315A most likely disrupt di-Ub binding via a direct loss of binding energy as they reside within the core portion of the mapped Ub-binding site (Figure 4A, 4B). For E315A, we showed that it compromised signal-dependent NF-κB activation (Figure 3F). One would have predicted that the A323P mutation could distort the local coiled coil structure of the LZ domain, but the A323D mutation is also defective in di-Ub binding. This suggests that A323 may directly contact Ub. Lack of global conformational disturbances of these mutations is confirmed by MALS and their ability to form disulfide-linked dimers (Figure 3C, 3D).

The A288G mutation did not cause any effect on di-Ub interaction. In addition, the mutant was able to form disulfide-linked dimer, precluding dramatic conformational changes. Since A288 is also quite far away from the mapped Ub-binding site, our data are consistent with the previous explanation that the mutant may have reduced temperature-dependent oligomer stability (Vinolo et al., 2006). Since R319Q did not show observable defects in K63-linked di-Ub interaction, the molecular basis of this disease mutation may be related to other aspects of NEMO function or its expression level and stability in vivo.

The Conserved Hydrophobic Surface of Ub Near I44 in Tandem di-Ub is a Major NEMO-binding Site

To elucidate the structural determinant on Ub for NEMO interaction, we first generated site-directed mutations on both Ub molecules of tandem di-Ub. The importance of hydrophobic residues of NEMO, especially near the center of the mapped Ub-binding site, prompted us to investigate the role of the hydrophobic patch of Ub near residue I44, which is a hot spot for protein interactions (Hurley et al., 2006). Mutations were also made of residues that exhibited chemical shift perturbations upon titration of ABIN-1 into mono-Ub (Wagner et al., 2008). Additional mutations were designed to cover a majority of the exposed surface of Ub.

The mutagenesis identified L8, I44 and V70 as crucial Ub residues for NEMO interaction because L8A, I44A and V70A mutations at both Ub molecules in the tandem di-Ub nearly abolished interactions with NEMO (Figure 5A, lanes 3, 6 and 9). H68A decreased, but not abolished NEMO interaction (lane 7). Residue R74, which resides on the C-terminal tail of Ub, was also identified as critical for NEMO Interaction (lane 24). Its importance may be consistent with the absolute requirement of acidic residues D311 and E315 of NEMO in their mutual interaction and may indicate the involvement of the linkage between the first and second Ub. In contrast, the remaining 24 mutations did not have apparent effects on NEMO binding. These data demonstrate that tandem di-Ub uses the conserved hydrophobic patch on the face of its five-stranded β-sheet for NEMO interaction. This same surface patch is typically recognized by other ubiquitin binding domains as well (Hurley et al., 2006).

Figure 5
Structure-based mutagenesis and NMR experiments on the NEMO: tandem di-Ub interaction

Mutagenesis and NMR Studies Identified Two Overlapping NEMO Binding Sites on the First and Second Ub of Tandem di-Ub

To determine whether the two Ub molecules of tandem di-Ub interact similarly with NEMO, we generated L8A, I44A, V70A and H68A mutations on either the first or second Ub molecules and compared their effects on NEMO interaction (Figure 5B, 5C). Strikingly, the I44A and V70A mutations in the first Ub had as strong effects on NEMO binding as the mutations on both Ub molecules while the same mutations in the second Ub had no effects on NEMO binding (Figure 5B, lanes 6-11), suggesting that I44 and V70 are mainly important for NEMO interaction in the first Ub. By contrast, residues L8 and H68 appear to be involved in the interaction of both Ub molecules with NEMO as the L8A and H68A mutations on two Ub molecules reduced NEMO interaction more than the same mutations on either the first or the second Ub (lanes 3–5, 12–14). The L8A and H68A mutations in the first Ub reduced tandem di-Ub interaction with NEMO more than the same mutations in the second Ub, suggesting that L8 and H68 are somewhat more important for the interaction of first Ub with NEMO. These data are very surprising and imply that the two Ub molecules in tandem di-Ub have significant differences in their interactions despite the dimeric symmetry of NEMO.

To determine whether the second Ub uses a different surface in NEMO interaction, we performed extensive mutagenesis that covered almost the entire surface of the tandem di-Ub (Figure 5C). Whereas most mutations had no observable effects in NEMO interactions, the T12D mutation of the second Ub had a selectively strong effect in NEMO binding (Figure 5B, lanes 30–31). Similarly, although the effects were less drastic, F4A and K6D mutations were partially defective when introduced in the second Ub but had no effect when introduced in the first Ub.

To investigate whether the C-terminal residues in either the first or the second Ub are important for NEMO interaction, we generated L73A and R74A mutations in either Ub molecule and a deletion of G75-G76 in the second Ub of the tandem di-Ub (Figure 5B, lanes 22–28). Both L73 and R74 appear to be involved in the first Ub interaction with NEMO whereas the C-terminal residues of the second Ub contribute minimally to the interaction.

Mapping of L8, I44, H68, V70, L73 and R74 onto the surface of the first Ub (Figure 5D, 5E) and mapping of F4, K6, L8, T12 and H68 onto the surface of the second Ub (Figure 5E, 5F) both showed continuous NEMO-binding sites. The surface patch of the first Ub is centered at the conserved hydrophobic patch while that of the second Ub is adjacent to and overlaps with the hydrophobic patch identified for the first Ub (Figure 5E). Five of the six identified residues of the first Ub exhibited drastic effects when mutated. By contrast, only one of the five identified residues of the second Ub is critical for NEMO interaction, suggesting that the first Ub contributes more binding energy to the overall interaction of tandem di-Ub with NEMO.

To provide an independent assessment on the interaction of NEMO with tandem di-Ub, we used NMR titration experiments. The proton-nitrogen TROSY-HSQC spectrum of N15-labeled tandem di-Ub is similar to published mono-Ub spectra (Wagner et al., 2008). However, a number of split resonances were observed indicating subtle differences in the environment of these residues in the two Ub molecules. Titration of NEMO to tandem di-Ub in 0.05 intervals of molar ratio led to severe line broadening and associated intensity attenuation of selective resonances (Figure 5G, Supplemental Figure S3). The line broadening is characteristic of an intermediate exchange regime on the NMR time scale, which is generally consistent with the micromolar affinity of the NEMO: tandem di-Ub interaction. Significantly, among residues with split peaks, preferential disappearance of one of the peaks occurred for residues I3, T14, L15, L56, S57, K63, E64, and L73. This observation strongly supports that the NEMO interactions of the two Ub molecules are different. Among non-split peaks with severe intensity decay are residues T7, L8, I13, V70, and G75, suggesting that these residues are affected by NEMO interactions in both Ub molecules. Mapping of these residues onto the Ub surface showed that they cover the same side of the Ub molecule identified from mutagenesis and is consistent with the involvement of two separate patches in Ub for NEMO interaction (Figure 5H).

The apparent involvement of Ub C-terminal regions in mutagenesis (L73 and R74) and NMR (L73) experiments prompted us to hypothesize that the linker between the two Ub molecules in tandem di-Ub may wrap around NEMO tightly. Indeed, deletion of a single residue G76 from the first Ub in tandem di-Ub completely abolished tandem di-Ub interaction with NEMO (Figure 5B, lane 33). We could not assess whether insertions of one or two Gly residues between the two Ub molecules affect interaction with NEMO because the insertion mutants were degraded to mono-Ub upon expression.

Mapping of Residues Important for NEMO Interaction with K63-linked di-Ub Using Mutagenesis and NMR Chemical Shift Perturbation

Given the similarity of surfaces that NEMO uses to recognize tandem and K63-linked di-Ub, we hypothesized that vice versa, similar surfaces on Ub are used for NEMO interaction. To test this, we first generated eight mutants of K63-linked di-Ub, L8A, I44A, V70A, and T12D on the proximal Ub and the same on the distal Ub. T14D was also made on either of the Ub molecules as a control. The yield of di-Ub in the L8A, I44A and V70A mutants were diminished by many fold, which is consistent with involvement of the conserved hydrophobic patch in both Ub charging by E1 and Ub interaction with the E2 acceptor site at Uev1A. Pull-down of these mutants using the CC2-LZ of NEMO showed that L8A, I44A and V70A mutations on the proximal Ub all led to impairment in NEMO interaction (Figure 6A, lanes 2–10). For the distal Ub, these mutations only had marginal effects. However, the L8A, I44A and V70A double mutations of the K63-linked di-Ub diminished interaction with NEMO more severely than the same mutations on the proximal Ub alone. This suggests that L8, I44 and V70 are also involved in distal Ub interaction with NEMO, albeit with less energetic contribution (Figure 6A). T12D on either proximal or distal Ub had minimal effects in NEMO interaction. T14D had no effects in NEMO interaction.

Figure 6
Structure-based mutagenesis and NMR experiments on the NEMO: K63-linked di-Ub interaction

Having established that the conserved hydrophobic patches of both proximal and distal Ub molecules are involved in NEMO interaction, we investigated whether the C-terminal regions of the Ub molecules also participate in this interaction. We generated L71A, L73A and R74A mutations on both Ub, the G76D mutation on the distal Ub, and deletion of G75-G76 on the proximal Ub (Figure 6A, lanes 16–28). The G76D mutation of the distal Ub affected the efficiency of K63-linked di-Ub synthesis drastically, but we managed to obtain a sufficient amount for this study. Pull-down of K63-linked di-Ub mutants by His-tagged NEMO showed that residues L71, L73, R74 and G76 of the distal Ub are all critical in NEMO interaction. By contrast, for the proximal Ub, only the beginning part of the C-terminal tail is important; the involvement decreases at R74 and becomes minimal at the last two residues. The importance of G76 suggests that the K63-linkage per se may be recognized by NEMO.

To provide an independent assessment on the interaction between K63-linked di-Ub and NEMO, we performed NMR chemical shift perturbation experiments. We produced K63-linked di-Ub proteins that are selectively labeled with N15 either in the distal Ub or the proximal Ub, K63-N15Ubd-Ubp or K63-Ubd-N15Ubp. The proton-nitrogen HSQC spectra of K63-N15Ubd-Ubp and K63-Ubd-N15Ubp are highly similar to each other and again to known mono-Ub HSQC spectra (Wagner et al., 2008). The resonance of residue K63 shifts in the spectrum of the proximal Ub labeled construct, consistent with ligation of the distal Ub to this residue. Similarly, the C-terminal residue (G76) in the spectrum of distal Ub labeled construct is undetectable, consistent with its involvement in the isopeptide linkage to K63 of the proximal Ub. Titration of NEMO CC2-LZ domain into either of the N15-labeled samples produced gradual chemical shift changes of resonances in the H1-N15 HSQC spectra with concomitant selective peak broadening and intensity reductions (Figure 6B, 6C). These spectral characteristics are consistent with an intermediate-fast exchange regime on the NMR time scale and in keeping with a lower affinity of the NEMO: K63-linked di-Ub interaction than the NEMO: tandem di-Ub interaction.

The patterns of chemical shift perturbation and peak broadening by NEMO were essentially identical for K63-N15Ubd-Ubp and K63-Ubd-N15Ubp (Figure 6D). In both cases, residues with largest chemical shift changes and severe peak broadening were clustered around L8, I44 and V70 shown by mutagenesis to be important for K63-linked di-Ub to interact with NEMO. Many C-terminal tail residues of both Ub molecules also exhibited significant chemical shift perturbation and peak broadening. Mapping of chemical shift changes larger than 0.02 ppm (0.02–0.07 ppm) and broadened residues in either the distal Ub (Figure 6E) or the proximal Ub (Figure 6F) to the surface of Ub showed that they agree very well with the mutagenesis data. They also reside on the same β-sheet surface of Ub shown to be critical for tandem di-Ub interaction and at the C-terminal tails. These data, in conjunction with the mutagenesis data, strongly suggest that K63-linked di-Ub interacts with NEMO using similar, albeit not identical, surfaces. Unlike tandem di-Ub interaction with NEMO, the proximal and distal Ub molecules in K63-linked di-Ub use the same conserved surface patches for interacting with NEMO. However, based on the degree of mutational effects, the most important parts of K63-linked di-Ub for NEMO interaction is the proximal Ub and the C-terminal tail of the distal Ub. It is possible that the hydrophobic patch of the distal Ub does not contact NEMO as optimally as the proximal Ub.

Models of Interactions of NEMO with Tandem and K63-linked di-Ub

Our mutational data suggest that NEMO uses an essentially identical surface for tandem and K63-linked di-Ub interaction. By contrast, the mutational and NMR data on the interaction of NEMO with its tandem and K63-linked di-Ub binding partners mapped similar, but not identical surfaces on the Ub molecules. On the β-sheet face of Ub, there are two patches that Ub uses for NEMO interaction. The first patch is composed of the conserved hydrophobic surface of Ub, which is used for both molecules of the K63-linked di-Ub and for the first Ub of the tandem di-Ub in NEMO interaction. The second patch is adjacent to and overlaps with the first patch on the same side of the β-sheet of Ub and is used for the second Ub of tandem di-Ub in NEMO interaction. Because of the intrinsic flexibility of the C-terminal tail, we did not use its experimental data in creating models of NEMO: di-Ub interactions.

We employed the high ambiguity driven protein-protein docking program HADDOCK (Dominguez et al., 2003) to generate the two types of NEMO: Ub complexes using the mutational and NMR data as restraints. For both types of interactions, we entered NEMO residues that reduced di-Ub interaction when mutated as “active residues” directly involved in the interaction. Those that did not cause observable effects in di-Ub interaction when mutated were entered as “passive residues”. To generate the first type of NEMO: Ub interaction, we did three different runs with 1) L8, I44, H68 and V70, residues implicated from mutagenesis, as “active residues”; 2) proximal Ub residues that undergone significant chemical shift perturbation during NEMO titration as “active residues”; and 3) distal Ub residues that undergone significant chemical shift perturbation during NEMO titration as “active residues”. All three runs gave the same cluster of low energy complexes.

To build the NEMO: K63-linked di-Ub complex, we generated the symmetry mate of the docked Ub that interacts with the other side of the NEMO dimer. This produced two symmetrical interactions with experimentally identified important residues of NEMO and Ub facing each other. Slight modifications to the conformations of the C-terminal tail (residues 71-76) of the distal Ub and the K63 side chain of the proximal Ub were needed to generate a geometrically correct K63-linkage (Figure 7A). In this model, the C-terminal tail of distal Ub wraps around NEMO, consistent with the mutagenesis data on the importance of this region. We also built the C-terminal tail of the proximal Ub so that its beginning part contacted NEMO. Inspection of the location of the N-terminus of the proximal Ub in this complex shows that it is 12 Å away from the C-terminal carboxylate of the distal Ub. This suggests that it is not possible for tandem di-Ub to interact with NEMO in the same fashion.

Figure 7
Model of NEMO: di-Ub interactions

To generate the second type of interface for building the NEMO: tandem di-Ub complex, we used residues F4, K6, L8, T12, and H68 that were implicated by mutagenesis in the interaction of the second Ub with NEMO as “active residues” in the docking run. We placed the low energy cluster of the docked second type complex with the first type complex as the starting point for the asymmetrical complex in the NEMO: tandem di-Ub interaction. Residue T12, which was identified as the most critical for the second type of interaction, resides at the center of this interface. Rebuilding of the C-terminal tail of the first Ub easily connected it to the N-terminus of the second Ub (Figure 7B).

A key feature of both NEMO: tandem di-Ub and NEMO: K63-linked di-Ub models is that the di-Ub stretches both its Ub molecules to clasp around NEMO as a hand gripping on a rope in a U-shaped fashion. The major Ub contacting sites of NEMO in both complexes are at the center of the surface patch identified from mutagenesis. In addition, the regions at or near the tandem and the K63-linkages are contacting NEMO. The modeling of NEMO: tandem di-Ub and NEMO: K63-linked di-Ub complexes provided an integral understanding on the similarity and differences in the recognition of tandem and K63-linked di-Ub by NEMO.


The transcription factor NF-κB regulates expression of numerous genes controlling immune and stress responses, inflammatory reaction and protection against apoptosis (Gilmore, 2006). NF-κB may be activated in many signaling pathways, including the TNF receptor superfamily, IL-1 receptor/Toll-like receptor superfamily, the T-cell receptor and the B-cell receptor (Scheidereit, 2006). While the upstream adaptors in these pathways may be different, they all induce K63-linked polyubiquitination. By interacting with K63-linked poly-Ub, NEMO integrates the diverse receptor activation signals to IKK signalosome recruitment and activation.

Our current studies provide a mechanistic basis for the interaction of NEMO with di-Ub. Unlike known helical motifs in Ub-interaction, dimeric NEMO possesses composite binding sites from both of its chains for interacting with tandem and K63-linked di-Ub. Certain degrees of asymmetry in binding energy and geometry are present in both tandem and K63-linked di-Ub interactions with NEMO. For tandem di-Ub, the first Ub uses its conserved hydrophobic patch while the second Ub uses an adjacent patch. While the C-terminal tail of the first Ub is important, the C-terminal tail of the second Ub does not seem to involve at all in the interaction as it points away from NEMO. The mutational effects suggest that the first Ub contributes many more critical residues (L8, I44, V70, L73 and R74) than the second Ub (T12) and is energetic dominant. For K63-linked di-Ub, the proximal Ub appears to have an optimal interaction at its conserved hydrophobic patch (L8, I44, V70, L71 and L73). A major contribution of the distal Ub is its C-terminal tail (L71, L73, R74 and G76); by contrast, its hydrophobic patch contributes much less to the NEMO interaction.

While most known Ub-binding domains recognize mono-Ub, the UBA domains seem to interact with either mono-Ub or di-Ub (Hurley et al., 2006; Varadan et al., 2005). UBA domains are compact three helical bundles. In the NMR-derived model of the hHR23A UBA2 domain in complex with K48-linked di-Ub, the two Ub molecules grip onto either side of the UBA domain (Varadan et al., 2005), reminiscent of our proposed modes of di-Ub interactions with NEMO. Although K63-linked di-Ub in principle could also grip onto UBA2 similarly as K48-linked di-Ub, it binds to UBA2 in a mono-Ub like mode with much less affinity. This difference was attributed to the additional energetic loss from immobilizing a second Ub in a K63-linked di-Ub because K63-linked chains possess little inter-Ub contacts (Varadan et al., 2005). By contrast, K48-linked chain adopts a closed conformation with stable inter-Ub contacts in which the individual Ub molecules are already immobilized relatively to each other (Cook et al., 1994).

An intrinsic conformational difference may also explain the affinity differential between tandem and K63-linked di-Ub. There are many split peaks in the NMR spectrum of tandem di-Ub, suggesting the presence of inter-Ub interactions. By contrast, and in agreement with previous data, the NMR spectra of K63-linked di-Ub samples that were selectively labeled either at the proximal or the distal Ub were almost identical. Therefore, tandem di-Ub may experience less energetic cost for immobilizing both Ub molecules upon NEMO Interaction in comparison with the NEMO: K63-linked di-Ub interaction. Consistent with this assessment, the distal Ub in K63-linked di-Ub appears to contribute less to the overall interaction. Another factor in the lower affinity of the NEMO: K63-linked di-Ub interaction may be due to a “sub-optimal” contact of the distal Ub hydrophobic patch with NEMO; although our model of the complex has the same mode of interaction at this site, we cannot exclude the possibility of subtle differences. It has been shown that longer K63-linked chains are more efficient in NEMO interaction, which is likely a result of further NEMO oligomerization and avidity (Wu et al., 2006). The weakest interaction of K48-linked di-Ub with NEMO may be due to the different geometric relationship of the two Ub molecules imposed by the K48-linkage. The consequence may be that the two Ub molecules cannot reach the equivalent Ub-binding sites of NEMO simultaneously or that the isopeptide linkage region does not have an optimal interaction with NEMO. However, it is possible that a K48-linked di-Ub also has some additional favorable contacts so that it interacts with NEMO better than a mono-Ub.

The robust affinity of NEMO to the natural Ub precursors such as tandem di-Ub raises the question whether this interaction may be relevant in vivo at certain physiological settings. In this regard, a most recent report showed that an E3 complex known as LUBAC interacts with NEMO, conjugates tandem polyubiquitin chains to NEMO and activate the canonical NF-κB pathway (Tokunaga et al., 2009).

Recently, the crystal structures of K63-linked di-Ub in complex with the deubiquitinating enzyme AMSH-LP (Sato et al., 2008) and with the Fab fragment of the specific antibody raised to recognize K63-linked chains (Newton et al., 2008) have been reported. Although the K63-linked di-Ub structures in both complexes are extended with little inter-Ub contact, they cannot be superimposed due to the complete difference in the spatial relationships of the proximal and distal Ub. Furthermore, the Ub surfaces used in complex formation are also distinct. While the distal Ub uses the hydrophobic patch for interaction with AMSH-LP, it is only peripherally involved in the Fab interaction. Neither of the hydrophobic patches of the proximal Ub is central to the recognitions. The conformation of K63-linked di-Ub in NEMO interaction is again completely different from either of the complexes above and the hydrophobic patches of both proximal and distal Ub are engaged in NEMO interaction. It appears then, that nature has developed a diverse repertoire of interactions to provide specificity of Ub recognition in biological processes.


Protein Expression, Purification, Crystallization and Structure Determination

NEMO and Ub were expressed in E. coli and purified by ion exchange and gel filtration chromatography. NEMO CC2-LZ (residues 246-337) were crystallized under 10% PEG1K and 10% PEG4K in Tris-HCl at pH 8.0. The structure was solved by single-wavelength anomalous diffraction. Mono-Ub mutants K63R-Ub and D77-Ub were generated for enzymatic synthesis of K63-linked di-Ub according to the published protocol (Piotrowski et al., 1997). For NMR experiments, the K63R-Ub and the D77-Ub mutants were expressed in minimal media supplemented with N15H4Cl.

Nuclear Magnetic Resonance (NMR) Spectroscopy

Samples for NMR experiments were made to a final protein concentration of 400 μM in the case of N15-labeled tandem di-Ub or 200 μM for K63-linked di-Ub with either the distal or the proximal Ub N15-labeled. NMR experiments were performed on a 600 MHz Varian INOVA equipped with a cryogenic probe, at a sample temperature of 25 °C. Spectra were recorded in succession starting with the collection of the control spectra (di-Ub alone) and by adding the corresponding molar ratio of NEMO in 0.05 molar increments.

Stable NEMO-expressing Cell Lines

NEMO-deficient MEFs stably expressing wild-type NEMO have been described (Wu et al., 2006), and NEMO-deficient MEFs stably reconstituted with the E315A mutant of NEMO were generated by the same method.

Supplementary Material

Supporing Info


We thank Drs. Narayanasami Sukumar, Kanagalaghatta Rajashankar and Igor Kourinov for data collection at NE-CAT of APS, Prof. Dinshaw Patel for use of the Micro Calorimetry System instrument, Dr. Haitao Li for help with the ITC experiments, Dr. Xuejun Jiang for providing E1 for enzymatic synthesis of K63-linked di-Ub, and Jin Wu for maintaining X-ray equipment and computers. Y-C Lo and S-C Lin are postdoctoral fellows of the Cancer Research Institute.


Accession Numbers: The coordinates have been deposited in the RCSB Protein Data Bank with the PDB code of 3FX0.


  • Agou F, Ye F, Goffinont S, Courtois G, Yamaoka S, Israel A, Veron M. NEMO trimerizes through its coiled-coil C-terminal domain. J Biol Chem. 2002;277:17464–17475. [PubMed]
  • Chen ZJ. Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol. 2005;7:758–765. [PMC free article] [PubMed]
  • Cook WJ, Jeffrey LC, Kasperek E, Pickart CM. Structure of tetraubiquitin shows how multiubiquitin chains can be formed. J Mol Biol. 1994;236:601–609. [PubMed]
  • Courtois G, Gilmore TD. Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene. 2006;25:6831–6843. [PubMed]
  • Dominguez C, Boelens R, Bonvin AM. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc. 2003;125:1731–1737. [PubMed]
  • Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell. 2006;22:245–257. [PubMed]
  • Filipe-Santos O, Bustamante J, Haverkamp MH, Vinolo E, Ku CL, Puel A, Frucht DM, Christel K, von Bernuth H, Jouanguy E, et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med. 2006;203:1745–1759. [PMC free article] [PubMed]
  • Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006;25:6680–6684. [PubMed]
  • Herscovitch M, Comb W, Ennis T, Coleman K, Yong S, Armstead B, Kalaitzidis D, Chandani S, Gilmore TD. Intermolecular disulfide bond formation in the NEMO dimer requires Cys54 and Cys347. Biochem Biophys Res Commun. 2008;367:103–108. [PMC free article] [PubMed]
  • Hurley JH, Lee S, Prag G. Ubiquitin-binding domains. Biochem J. 2006;399:361–372. [PMC free article] [PubMed]
  • Newton K, Matsumoto ML, Wertz IE, Kirkpatrick DS, Lill JR, Tan J, Dugger D, Gordon N, Sidhu SS, Fellouse FA, et al. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell. 2008;134:668–678. [PubMed]
  • Oeckinghaus A, Wegener E, Welteke V, Ferch U, Arslan SC, Ruland J, Scheidereit C, Krappmann D. Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation. EMBO J. 2007;26:4634–4645. [PMC free article] [PubMed]
  • Piotrowski J, Beal R, Hoffman L, Wilkinson KD, Cohen RE, Pickart CM. Inhibition of the 26 S proteasome by polyubiquitin chains synthesized to have defined lengths. J Biol Chem. 1997;272:23712–23721. [PubMed]
  • Sato Y, Yoshikawa A, Yamagata A, Mimura H, Yamashita M, Ookata K, Nureki O, Iwai K, Komada M, Fukai S. Structural basis for specific cleavage of Lys 63-linked polyubiquitin chains. Nature. 2008;455:358–362. [PubMed]
  • Scheidereit C. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene. 2006;25:6685–6705. [PubMed]
  • Sebban-Benin H, Pescatore A, Fusco F, Pascuale V, Gautheron J, Yamaoka S, Moncla A, Ursini MV, Courtois G. Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti. Hum Mol Genet. 2007;16:2805–2815. [PubMed]
  • Tokunaga F, Sakata SI, Saeki Y, Satomi Y, Kirisako T, Kamei K, Nakagawa T, Kato M, Murata S, Yamaoka S, et al. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol 2009 [PubMed]
  • Varadan R, Assfalg M, Raasi S, Pickart C, Fushman D. Structural determinants for selective recognition of a Lys48-linked polyubiquitin chain by a UBA domain. Mol Cell. 2005;18:687–698. [PubMed]
  • Vinolo E, Sebban H, Chaffotte A, Israel A, Courtois G, Veron M, Agou F. A point mutation in NEMO associated with anhidrotic ectodermal dysplasia with immunodeficiency pathology results in destabilization of the oligomer and reduces lipopolysaccharide- and tumor necrosis factor-mediated NF-kappa B activation. J Biol Chem. 2006;281:6334–6348. [PubMed]
  • Wagner S, Carpentier I, Rogov V, Kreike M, Ikeda F, Lohr F, Wu CJ, Ashwell JD, Dotsch V, Dikic I, et al. Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins. Oncogene. 2008;27:3739–3745. [PubMed]
  • Wu CJ, Ashwell JD. NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-kappaB activation. Proc Natl Acad Sci U S A. 2008;105:3023–3028. [PMC free article] [PubMed]
  • Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected] Nat Cell Biol. 2006;8:398–406. [PubMed]
PubReader format: click here to try


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...